Search
for
Sort by
Research 61–90 of 127
- Recent Insights in Multi‐Target Drugs in Pharmacology and Medicinal Chemistry
- Drug utilization pattern and adverse drug reactions of chemotherapy in pediatric patients at Muhimbili National Hospital, Tanzania
- Repurposing Auranofin for Oncology and Beyond: A Brief Overview of Clinical Trials as Mono- and Combination Therapy
- How Biodegradable Polymers Can be Effective Drug Delivery Systems for Cannabinoids? Prospectives and Challenges
- Referee report. For: Drug utilization pattern and adverse drug reactions of chemotherapy in pediatric patients at Muhimbili National Hospital, Tanzania [version 1; peer review: 1 approved, 1 approved with reservations]
- Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- Alpinetin promotes hair regeneration via activating hair follicle stem cells
- Preclinical Development and Phase I Study of ZSYY001, a Polymeric Micellar Paclitaxel for Advanced Solid Tumor
- Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel
- Pharmacogenomic variation and chemotherapy-related toxicity profiles in pediatric patients with cancer in Tanzania: a cross-sectional study
- Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma
- Food and medicine homology: a potential nutritional intervention strategy for post-acute COVID-19 syndrome
- Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs
- Potential Pharmacological Activities of Pumpkin Seeds as a Functional Food: A Comprehensive Review
- BIOBRAN MGN-3
- Formestane Preferred as Second-Line Therapy in Advanced Breast Cancer
- Aldesleukin
- Liquid Protein Diets and Telogen Effluvium: A Case Report
- Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
- Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study
- Understanding Microemulsions and Nanoemulsions in (Trans)Dermal Delivery
- Next-Gen Therapeutics for Skin Cancer: Nutraceuticals
- Clinical Development of Topoisomerase-Interactive Drugs
- Small cell lung cancer: Results of a phase II study of 1,2,4 triglycidylurazol
- “Spigo nardo”: from the Erbario Estense a possible solution for its taxonomical attribution
- Prevalence and Partern of Early Adverse Reactions in Cancer Patients Receiving Chemotherapy at Ocean Road Cancer Institute
- Monocyclic Aromatic Compounds
- Predicting Quality of Life from Symptom Experience and Symptom Management Behaviors in Women with Ovarian Cancer Receiving Chemotherapy: A Cross-Sectional Study.
- Nutraceutical : An emerging Pharmaceutical Towards Prevention Of Diseases
- Stress Inhibits Hair Growth in Mice by Induction of Premature Catagen Development and Deleterious Perifollicular Inflammatory Events via Neuropeptide Substance P-Dependent Pathways